共 23 条
- [21] CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer (Aug, 10.1007/s12094-022-02881-0, 2022) CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (11): : 2251 - 2253